UB Paderborn / Katalog / Suche / in CDI

A Review of Mixed‐Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis

CPT: pharmacometrics and systems pharmacology, 2014-05, Vol.3 (5), p.1-10

2014

Volltextzugriff (PDF)

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents

Journal of theoretical biology, 2006-12, Vol.243 (4), p.532-541

2006

Volltextzugriff (PDF)

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice

Journal of theoretical biology, 2013-03, Vol.320, p.86-99

2013

Volltextzugriff (PDF)

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation

CPT: pharmacometrics and systems pharmacology, 2017-08, Vol.6 (8), p.496-498

2017

Volltextzugriff (PDF)

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

CPT: pharmacometrics and systems pharmacology, 2015-11, Vol.4 (11), p.660-668

2015

Volltextzugriff (PDF)

Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias

Annals of oncology, 2010-08, Vol.21 (8), p.1643-1650

2010

Volltextzugriff (PDF)

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy

Journal of neuro-oncology, 2013-11, Vol.115 (2), p.261-265

2013

Volltextzugriff (PDF)

Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth

Oncogene, 2011-04, Vol.30 (14), p.1631-1642

2011

Volltextzugriff (PDF)

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

CPT: pharmacometrics and systems pharmacology, 2015-12, Vol.4 (12), p.728-737

2015

Volltextzugriff (PDF)

Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs

CPT: pharmacometrics and systems pharmacology, 2016-11, Vol.5 (11), p.636-645

2016

Volltextzugriff (PDF)

Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings

CPT: pharmacometrics and systems pharmacology, 2015-12, Vol.4 (12), p.720-727

2015

Volltextzugriff (PDF)

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

CPT: pharmacometrics and systems pharmacology, 2015-09, Vol.4 (9), p.495-497

2015

Volltextzugriff (PDF)

A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin’s lymphoma: investigation of the current protocol through theoretical modelling results

Bulletin of mathematical biology, 2005, Vol.67 (1), p.79-99

2005

Volltextzugriff (PDF)

Chemotherapy may be delivered based on an integrated view of tumour dynamics

IET systems biology, 2009-05, Vol.3 (3), p.180-190

2009

Volltextzugriff (PDF)

Time-Course Analysis of Main Markers of Primary Infection in Cats with the Feline Immunodeficiency Virus

Computational and mathematical methods in medicine, 2012-01, Vol.2012, p.342602-9

2012

Volltextzugriff (PDF)

Theme A: Modeling and simulation in biomedical research. Results and future works

Ingénierie et recherche biomédicale, 2013-02, Vol.34 (1), p.3-5

2013

Volltextzugriff (PDF)

The Use of Hybrid Cellular Automaton Models for Improving Cancer Therapy

Cellular Automata, 2004, p.444-453

2004

Volltextzugriff (PDF)

Schedule optimization of a novel tumor-targeted IL-2 variant immunocytokine by integration of human in vivo immune cell kinetics and functional imaging

Annals of oncology, 2016-11, Vol.27, p.viii10-viii10

2016

Volltextzugriff (PDF)

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation: Methodologies for Quantitative Systems

CPT: pharmacometrics and systems pharmacology, 2017-08, Vol.6 (8), p.496-498

2017

Volltextzugriff (PDF)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

CPT: pharmacometrics and systems pharmacology, 2015-06, Vol.4 (6), p.316-319

2015

Volltextzugriff (PDF)

Major prognostic value of modeled AUC hCG-AFP , a dynamic kinetic marker characterizing tumor marker decline of nonseminomatous germ cell tumors (NSGCT) intermediate-poor-risk patients according to the IGCCCG

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5085-5085

2009

Volltextzugriff (PDF)

A mathematical model of diffuse low-grade gliomas treated with PCV chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2065-2065

2011

Volltextzugriff (PDF)

Theme A: Modeling and simulation in biomedical research. Results and future works

Ingénierie et recherche biomédicale, 2013-02, Vol.34 (1), p.3-5

2013

Volltextzugriff (PDF)

A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin?s lymphoma: investigation of the current protocol through theoretical modelling results

Bulletin of mathematical biology, 2005-01, Vol.67 (1), p.79-99

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A Review of Mixed‐Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis

The Use of Model-Based Tumor-Size Metrics to Predict Survival

A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation

Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma

Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy

Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs

Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin’s lymphoma: investigation of the current protocol through theoretical modelling results

Chemotherapy may be delivered based on an integrated view of tumour dynamics

Time-Course Analysis of Main Markers of Primary Infection in Cats with the Feline Immunodeficiency Virus

Theme A: Modeling and simulation in biomedical research. Results and future works

The Use of Hybrid Cellular Automaton Models for Improving Cancer Therapy

Schedule optimization of a novel tumor-targeted IL-2 variant immunocytokine by integration of human in vivo immune cell kinetics and functional imaging

Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation: Methodologies for Quantitative Systems

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

Major prognostic value of modeled AUC hCG-AFP , a dynamic kinetic marker characterizing tumor marker decline of nonseminomatous germ cell tumors (NSGCT) intermediate-poor-risk patients according to the IGCCCG

A mathematical model of diffuse low-grade gliomas treated with PCV chemotherapy

Theme A: Modeling and simulation in biomedical research. Results and future works

A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin?s lymphoma: investigation of the current protocol through theoretical modelling results

Suchergebnisse filtern